Save Product
Product Details
Product Overview
The Human IL-17F ELISA Kit is a ready‑to‑use immunoassay kit specifically designed for the quantification of native and recombinant human IL-17F in biological samples, including cell culture supernates, serum and plasma. Our ELISA kit offers multiple advantages:
Product Specifications
Assay TypeSandwich-ELISAAnalyteIL-17FFormat96-wells plate breakable into 12 x 8 wells stripsReactivityHumanSensitivity10 pg/mLAssay Time2.75 hrSample volume50 μLRange12.5 pg/mL-800 pg/mLSample TypeFor the quantitative determination of human IL-17F in serum, plasma and cell supernatant.Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.
Application
The kit is developed for the quantification of native and recombinant human IL-17F in serum, plasma and cell culture supernates.
It is for research use only.
Workflow
Storage
Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
Materials Provided
IDComponentsSizeCEA233-C01Pre-coated Anti-IL-17F Antibody Microplate1 plateCEA233-C02Human IL-17F Standard200 ng/mL×2CEA233-C03Biotin-Anti-IL-17F Antibody Con. Solution100 μLCEA233-C04Biotin-Antibody Dilution Buffer8 mLCEA233-C05Streptavidin-HRP Con. Solution500 μLCEA233-C06Streptavidin-HRP Dilution Buffer15 mLCEA233-C0720× Washing Buffer50 mLCEA233-C08Sample Dilution Buffer15 mL×2CEA233-C09Substrate Solution12 mLCEA233-C10Stop Solution6 mLACRO Quality Management System
Customers Also Viewed
Performance Data
Typical Data
Please refer to DS document for the assay protocol.
For each experiment, a standard curve needs to be set for each microplate, and the specific OD value may vary depending on different laboratories, testers, or equipment. The following example data is for reference only. The sample concentration was calculated based on the results of the standard curve. The minimum detectable concentration of IL-17F is less than 10 pg/mL.
Sample Values
Peripheral blood mononuclear cells from a single donor (PBMCs; seeded at 1 x 10⁶/mL) were cultured in RPMI 1640 supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/mL penicillin, and 100 ug/mL streptomycin sulfate. Cells were left untreated or treated with 10ug/mL of PHA for 1, 3 and 5days.
Intra-Assay Statistics
Eight replicates of each of 3 samples containing different IL-17F concentrations were tested in one assay. Acceptable criteria: CV＜10%.
Inter-Assay Statistics
Three samples containing different concentrations of IL-17F were tested in independent assays. Acceptable criteria: CV<15%.
Recovery
Recombinant IL-17F was spiked into 3 human serum samples, and then analyzed. The average recovery of IL-17F for serum samples is 97.21%.
Customer Reviews Writing Reviews
Recent Advances
Drug Development Progress- English Name：
Interleukin-17F
- Category：
- Approved Drugs：
0 Details
- Drugs in Clinical Trials：
5 Details
- Highest Development Stage：
NDA/BLA
Contact Us
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
Drug Candidate Licensing